avrg: GSE58827: Dynamics of the Mouse Liver
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_109010955 Show fit | 4.47 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
synaptotagmin I |
|
chr10_+_84838143 Show fit | 4.45 |
ENSMUST00000095388.4
|
regulatory factor X, 4 (influences HLA class II expression) |
|
chr2_+_102658640 Show fit | 4.25 |
ENSMUST00000080210.3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
chr2_+_23068168 Show fit | 2.95 |
ENSMUST00000028121.7
ENSMUST00000114523.2 ENSMUST00000144088.1 |
acyl-Coenzyme A binding domain containing 5 |
|
chr5_-_53213447 Show fit | 2.88 |
ENSMUST00000031090.6
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
|
chr12_+_8771317 Show fit | 2.76 |
ENSMUST00000020911.7
|
syndecan 1 |
|
chr8_+_76899772 Show fit | 2.54 |
ENSMUST00000109913.2
|
nuclear receptor subfamily 3, group C, member 2 |
|
chr6_-_72617000 Show fit | 2.48 |
ENSMUST00000070524.4
|
trans-golgi network protein |
|
chr19_+_26605106 Show fit | 2.47 |
ENSMUST00000025862.7
ENSMUST00000176030.1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
|
chr2_+_71981184 Show fit | 2.45 |
ENSMUST00000090826.5
ENSMUST00000102698.3 |
Rap guanine nucleotide exchange factor (GEF) 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.9 | 4.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 4.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 3.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 2.9 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 2.8 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.9 | 2.8 | GO:0048627 | myoblast development(GO:0048627) |
0.8 | 2.5 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.3 | 2.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.6 | 2.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 4.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 3.2 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 3.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 2.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 2.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.5 | 2.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 1.9 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.7 | 4.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 3.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 3.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 3.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 3.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 2.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.8 | 2.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 2.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 2.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 4.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 2.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 4.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 4.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 4.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 2.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 2.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |